Related Experiment Videos
Direct angiotensin converting enzyme inhibitor-mediated venodilation
1Department of Medicine, University of Western Ontario, London, Canada.
Clinical Pharmacology and Therapeutics
|May 1, 1996
Summary
Enalaprilat, an angiotensin converting enzyme inhibitor, causes local vasodilation in human hand veins. This effect, dependent on vessel size and constriction, may contribute to the drug's overall clinical impact.
Area of Science:
- Pharmacology
- Cardiovascular Physiology
Background:
- Angiotensin converting enzyme inhibitors (ACEIs) are known for systemic vasodilation via angiotensin II inhibition.
- Local mechanisms of vasodilation by ACEIs have been proposed but not fully elucidated.
- This study investigated the local vasodilator effects of enalaprilat in human dorsal hand veins.
Purpose of the Study:
- To determine if the ACE inhibitor enalaprilat induces local vasodilation in human dorsal hand veins.
- To assess the dose-dependency and conditions influencing enalaprilat-mediated vasodilation.
- To compare the local vasodilator potency of enalaprilat with other agents.
Main Methods:
- Infusion of enalaprilat into human dorsal hand veins.
- Measurement of vein compliance using the linear variable differential transducer technique.
- Assessment of effects in small and large veins, with and without exogenous norepinephrine or cooling-induced vasoconstriction.
Main Results:
- Enalaprilat induced dose-dependent vasodilation in small dorsal hand veins at cooler temperatures (ED50 = 12 ng/min).
- Maximal vasodilation with enalaprilat was comparable to insulin and less than nitroglycerin.
- In warmer conditions, enalaprilat required norepinephrine preconstriction for vasodilation in small vessels (ED50 = 5.1 ng/min).
Conclusions:
- Enalaprilat mediates local vasodilation in dorsal hand veins.
- The local vasodilator effect is dependent on vessel size and the presence of vasoconstriction.
- These local effects may play a role in the clinical hemodynamic actions of ACE inhibitors.